Item 1 of 1 (back to results) enalaprilat dihydrate The dihydrate form of enalaprilat, an angiotensin-converting enzyme (ACE) inhibitor that is used (often in the form of its prodrug, enalapril) in the treatment of hypertension and heart failure, for reduction of proteinuria and renal disease in patients with nephropathies, and for the prevention of stroke, myocardial infarction, and cardiac death in high-risk patients. Unlike enalapril, enalaprilat is not absorbed by mouth but is administered by intravenous injection.

Current search: 03. Biological Effects of Specific Chemicals: biochemical uses [CHEBI:52206] > enzyme inhibitor [CHEBI:23924] > angiotensin-converting enzyme inhibitor [CHEBI:35457] > enalaprilat dihydrate [CHEBI:59877] × Select any link to see items in a related category. more general categories    information about this item 03. Biological Effects of Specific Chemicals  03. Biological Effects of Specific Chemicals  biochemical uses [CHEBI:52206] (3306)   enzyme inhibitor [CHEBI:23924] (825)   angiotensin-converting enzyme inhibitor [CHEBI:35457] (14)   enalaprilat dihydrate [CHEBI:59877] (1) 05. Industrial Uses  05. Industrial Uses  pharmaceutical [CHEBI:52217] (1978)   drug [CHEBI:23888] (1930)   antihypertensive agent [CHEBI:35674] (104)   enalaprilat dihydrate [CHEBI:59877] (1) 08. Chemical Category  08. Chemical Category  polyatomic entity [CHEBI:36357] (18777)   heteroatomic molecular entity [CHEBI:37577] (13672)   addition compound [CHEBI:35504] (113)   hydrate [CHEBI:35505] (111)   enalaprilat dihydrate [CHEBI:59877] (1) ChEBI Compound Accession Identifier:   [CHEBI:59877] ChEBI Compound Description:   The dihydrate form of enalaprilat, an angiotensin-converting enzyme (ACE) inhibitor that is used (often in the form of its prodrug, enalapril) in the treatment of hypertension and heart failure, for reduction of proteinuria and renal disease in patients with nephropathies, and for the prevention of stroke, myocardial infarction, and cardiac death in high-risk patients. Unlike enalapril, enalaprilat is not absorbed by mouth but is administered by intravenous injection. ChEBI Compound Identification Number:   59877 ChEBI InChI Value:   "InChI=1S/C18H24N2O5.2H2O/c1-12(16(21)20-11-5-8-15(20)18(24)25)19-14(17(22)23)10-9-13-6-3-2-4-7-13;;/h2-4,6-7,12,14-15,19H,5,8-11H2,1H3,(H,22,23)(H,24,25);2*1H2/t12-,14-,15-;;/m0../s1" ChEBI InChIKey Value:   MZYVOFLIPYDBGD-MLZQUWKJSA-N ChEBI Compound Name:   enalaprilat dihydrate ChEBI SMILES Value:   O.O.C[C@H](N[C@@H](CCc1ccccc1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O ChEBI Substance ID:   99319603 ChEBI URL:   ChEBI:59877 ChemSpider ID:   5292946 Ontomatica Chemical Accession Key (OnChAKey):   MZYVOFLIPYDBGD_MLZQUWKJSA_N_000_000000 PubChem Compound ID:   6917719